Perry G, Friedman R, Kang D H, Manetto V, Autilio-Gambetti L, Gambetti P
Division of Neuropathology, Case Western Reserve University, Cleveland, OH 44106.
Brain Res. 1987 Sep 15;420(2):233-42. doi: 10.1016/0006-8993(87)91243-1.
Antibodies were raised to paired helical filament (PHF) enriched fractions obtained from brains of individuals with Alzheimer disease by extraction with ionic detergent followed by sucrose gradient centrifugation. Electron microscopic examination showed that the fractions were enriched in Alzheimer PHF but contained also lipofuscin, amyloid, granular material and membranous elements. Analysis of these fractions with SDS-PAGE stained with Coomassie blue showed only a faint band at approximately 60 kDa while most of the material was excluded from the stacking gel. BALB/c mice were injected weekly with 100 or 200 micrograms of these fractions or corresponding fractions from age-matched control brains. The 3 mice injected with Alzheimer brain, but not the 5 mice injected with control brain fractions, produced antibodies that reacted with central and peripheral nervous system axons, Alzheimer neurofibrillary tangles in intact tissue as well as with isolated, SDS-treated paired helical filaments. In gel strips antibodies from all 3 mice injected with Alzheimer brain fractions reacted with the 200-kDa and 168-kDa but not the 68-kDa neurofilament subunits. The 3 antisera reacted also with some forms of the microtubule-associated protein tau. Adsorptions with the insoluble fraction from Alzheimer but not from control brains blocked staining of axons and NFT by all 3 antisera. Adsorption with highly purified neurofilament proteins or with a preparation containing the 200-kDa and 168-kDa neurofilament subunits blocked axon and NFT immunostaining only in one antiserum. Adsorptions with microtubule protein, heat-stable microtubule-associated protein, or a preparation of tau did not completely block immunostaining by any of the 3 antisera. These results demonstrate that fractions enriched with Alzheimer paired helical filaments contain insoluble neurofilament, tau and other yet unidentified antigens.
通过离子去污剂提取,随后进行蔗糖梯度离心,从阿尔茨海默病患者大脑中获得富含双螺旋丝(PHF)的组分,并以此制备抗体。电子显微镜检查显示,这些组分富含阿尔茨海默病PHF,但也含有脂褐素、淀粉样蛋白、颗粒物质和膜性成分。用考马斯亮蓝染色的SDS-PAGE分析这些组分,仅在约60 kDa处显示出一条 faint 条带,而大部分物质被排除在堆积胶之外。每周给BALB/c小鼠注射100或200微克这些组分或来自年龄匹配对照大脑的相应组分。注射阿尔茨海默病大脑组分的3只小鼠产生了抗体,而注射对照大脑组分的5只小鼠未产生抗体,这些抗体与中枢和外周神经系统轴突、完整组织中的阿尔茨海默病神经原纤维缠结以及分离的、经SDS处理的双螺旋丝发生反应。在凝胶条上,注射阿尔茨海默病大脑组分的所有3只小鼠的抗体与200-kDa和168-kDa神经丝亚基发生反应,但不与68-kDa神经丝亚基发生反应。这3种抗血清也与某些形式的微管相关蛋白tau发生反应。用阿尔茨海默病而非对照大脑的不溶性组分进行吸附,可阻断所有3种抗血清对轴突和NFT的染色。用高度纯化的神经丝蛋白或含有200-kDa和168-kDa神经丝亚基的制剂进行吸附,仅在一种抗血清中阻断轴突和NFT免疫染色。用微管蛋白、热稳定微管相关蛋白或tau制剂进行吸附,均不能完全阻断3种抗血清中的任何一种的免疫染色。这些结果表明,富含阿尔茨海默病双螺旋丝的组分含有不溶性神经丝、tau和其他尚未鉴定的抗原。